Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Please check the official MEDVi website for the most current rates and promotional options
Key players driving the GLP-1 market include Novo Nordisk, Eli Lilly, Pfizer, AstraZeneca, Roche, Sanofi, Boehringer Ingelheim, and Tonghua Dongbao Pharmaceutical
Byetta is indicated as a addition to diet and exercise in adults with type 2 diabetes and is dosed twice daily via subcutaneous injection
8.5 Geriatric Use In the pool of glycemic control trials, 1,229 (30%) RYBELSUS-treated patients were 65 years of age and over and 199 (5%) RYBELSUS-treated patients were 75 years of age and over [see Clinical Studies (14)]
US$ 24.68
US$ 23.20
US$ 24.53
US$ 22.62
US$ 21.54
